Sentient Science and the CMI faculty were recently awarded funding from the U.S. Navy Small Business Technology Transfer (STTR) for their proposed Bioelectronic Fusion Sensor System.
To address the Navy’s need for a common, scalable, platform for multi-modal 1pA level current sensing for Electrocardiogram (ECG), Electroencephalogram (EEG), and Electrodermal Response (EDR) to be fielded as a miniature wearable device with non-contact electrodes, Sentient and UB propose to develop the Bioelectronic Fusion Sensor System (BioFuSenS. BioFuSenS will be a modular, real-time, low cost, low bandwidth, open standards-based system that, includes autonomous prediction, health monitoring and management.
In Phase I, the team will demonstrate feasibility through transistor-level IC simulations, thorough nonlinear systems analysis, and data-model fusion and noise handling simulations for ECG sensing. In Phase II, they will develop and validate a prototype, demonstrate multi-modal, model-based detection with noise filtering, and optimize the design to meet size, weight, power, and cost (SWAP-C) requirements.
In Sentient CEOWard Thomas’s words: “This is such great news. The sensor in the cap commercial plan is a winner. Our first medical sensor funding. Our first team win with The University at Buffalo! I'm sure the first of many.”
“I’ve met some amazing people at UB…I mean this with my heart and soul."
- Raj Suchak, Founder
“Through the collaboration with UB, I got the first IRB approval for acquiring human tissues for our experiment.”
- Dr. Vladik Sandler, CEO/CSO